Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases

Clinical trial NCT06549296 · SUSPENDED

Trial details

NCT number: NCT06549296
Sponsor: Nanjing Bioheng Biotech Co., Ltd.
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Systemic Sclerosis ANCA Associated Vasculitis Idiopathic Inflammatory Myopathies Sjogren's Syndrome Autoimmune Diseases

Start date: 2024-09-13
Primary completion: 2026-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.